The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sickle Cell Market Research Report 2025
Synopsis
The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.
The global Sickle Cell market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell.
Report Scope
The Sickle Cell market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sickle Cell market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bristol-Myers Squibb
Takeda
Bluebird Bio
Global Blood Therapeutics
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.
The global Sickle Cell market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell.
Report Scope
The Sickle Cell market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sickle Cell market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bristol-Myers Squibb
Takeda
Bluebird Bio
Global Blood Therapeutics
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Sickle Cell Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Market Perspective (2019-2030)
2.2 Sickle Cell Growth Trends by Region
2.2.1 Global Sickle Cell Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sickle Cell Historic Market Size by Region (2019-2024)
2.2.3 Sickle Cell Forecasted Market Size by Region (2025-2030)
2.3 Sickle Cell Market Dynamics
2.3.1 Sickle Cell Industry Trends
2.3.2 Sickle Cell Market Drivers
2.3.3 Sickle Cell Market Challenges
2.3.4 Sickle Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Players by Revenue
3.1.1 Global Top Sickle Cell Players by Revenue (2019-2024)
3.1.2 Global Sickle Cell Revenue Market Share by Players (2019-2024)
3.2 Global Sickle Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Revenue
3.4 Global Sickle Cell Market Concentration Ratio
3.4.1 Global Sickle Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Revenue in 2023
3.5 Sickle Cell Key Players Head office and Area Served
3.6 Key Players Sickle Cell Product Solution and Service
3.7 Date of Enter into Sickle Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Breakdown Data by Type
4.1 Global Sickle Cell Historic Market Size by Type (2019-2024)
4.2 Global Sickle Cell Forecasted Market Size by Type (2025-2030)
5 Sickle Cell Breakdown Data by Application
5.1 Global Sickle Cell Historic Market Size by Application (2019-2024)
5.2 Global Sickle Cell Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sickle Cell Market Size (2019-2030)
6.2 North America Sickle Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sickle Cell Market Size by Country (2019-2024)
6.4 North America Sickle Cell Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Market Size (2019-2030)
7.2 Europe Sickle Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sickle Cell Market Size by Country (2019-2024)
7.4 Europe Sickle Cell Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Market Size (2019-2030)
8.2 Asia-Pacific Sickle Cell Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sickle Cell Market Size by Region (2019-2024)
8.4 Asia-Pacific Sickle Cell Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Market Size (2019-2030)
9.2 Latin America Sickle Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sickle Cell Market Size by Country (2019-2024)
9.4 Latin America Sickle Cell Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Market Size (2019-2030)
10.2 Middle East & Africa Sickle Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sickle Cell Market Size by Country (2019-2024)
10.4 Middle East & Africa Sickle Cell Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Sickle Cell Introduction
11.1.4 Novartis Revenue in Sickle Cell Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Sickle Cell Introduction
11.2.4 Bristol-Myers Squibb Revenue in Sickle Cell Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Sickle Cell Introduction
11.3.4 Takeda Revenue in Sickle Cell Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Bluebird Bio
11.4.1 Bluebird Bio Company Detail
11.4.2 Bluebird Bio Business Overview
11.4.3 Bluebird Bio Sickle Cell Introduction
11.4.4 Bluebird Bio Revenue in Sickle Cell Business (2019-2024)
11.4.5 Bluebird Bio Recent Development
11.5 Global Blood Therapeutics
11.5.1 Global Blood Therapeutics Company Detail
11.5.2 Global Blood Therapeutics Business Overview
11.5.3 Global Blood Therapeutics Sickle Cell Introduction
11.5.4 Global Blood Therapeutics Revenue in Sickle Cell Business (2019-2024)
11.5.5 Global Blood Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
